Business Insider
My Markets Watchlist
Markets Stocks

TransMedics Group Inc Registered Shs Stock , TMDX

131.35 +1.29 +0.99%
03:59:59 PM EDT 6/27/2025 BTT
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar

On Friday 06/27/2025 the closing price of the TransMedics Group Inc Registered Shs share was $130.06 on BTT. Compared to the opening price on Friday 06/27/2025 on BTT of $131.14, this is a drop of 0.83%. TransMedics Group Inc Registered Shs's market capitalization is $3.56 B by 33.83 M shares outstanding.

TransMedics Group Stock Snapshot

112.05
Bid
100.00
Bid Size
150.48
Ask
100.00
Ask Size
6/27/2025
Date
3:59 PM
Time
19,173.00
Volume
130.06
Prev. Close
131.14
Open
4.45 B
Market Cap in USD
33.83 M
Number of Shares
33.83 M
Total Number of Shares
129.66
Day Low
132.93
Day High
131.35
55.01
52 Week Low
177.30
52 Week High
131.35
0.00
Dividend in USD
0.00
Dividend Yield
61.92
P/E Ratio
96.29
Free Float in %
1.01
EPS in USD
6.80
Book Value per Share in USD
1.39
Cash Flow per Share in USD

Historical Prices for TransMedics Group

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

TransMedics Group Analyst Data

Total Analysts: 22
Buy Ratings: 17 Neutral Ratings: 5 Sell Ratings: 0
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 50.00 Median: 112.86 Highest: 170.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

TransMedics Group Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price
06/17/25 Oppenheimer & Co. Inc.
Maintained Buy $150
06/04/25 Piper Sandler
Maintained Buy $145
06/03/25 Needham & Company, LLC
Maintained Hold
05/09/25 Oppenheimer & Co. Inc.
Maintained Buy $130
05/09/25 Piper Sandler
Maintained Buy $125
04/29/25 Piper Sandler
Maintained Buy $105
04/23/25 Needham & Company, LLC
Maintained Hold
03/26/25 Needham & Company, LLC
Maintained Hold
03/11/25 Capital Depesche
Maintained Buy $104
02/05/25 Needham & Company, LLC
Maintained Hold
07/15/24 Morgan Stanley
Maintained Hold $145
07/15/24 Piper Sandler
Maintained Buy $170
06/21/24 Piper Sandler
Maintained Buy $120
06/04/24 Stephens Inc.
Maintained Buy $151
05/01/24 Capital Depesche
Maintained Buy $117
05/01/24 J.P. Morgan
Maintained Buy $127
05/01/24 Piper Sandler
Maintained Buy $120
05/01/24 Oppenheimer & Co. Inc.
Maintained Buy $125
03/28/24 Piper Sandler
Maintained Buy $95
02/28/24 Morgan Stanley
Maintained Hold $95
02/27/24 J.P. Morgan
Maintained Buy $105
02/27/24 Oppenheimer & Co. Inc.
Maintained Buy $105
12/04/23 Morgan Stanley
Maintained Hold $75
11/07/23 J.P. Morgan
Maintained Buy $70
11/07/23 Morgan Stanley
Maintained Hold $54
10/13/23 Morgan Stanley
Maintained Hold $50
07/19/23 William Blair
Maintained Buy

TransMedics Group Estimates* in USD

  2025 2026 2027 2028 2029
Revenue 580 701 827 1,006 1,120
Dividend - - - - -
Dividend Yield (in %) - - - - -
EPS 1.84 2.54 3.24 3.67 4.26
P/E Ratio 71.53 51.81 40.52 35.87 30.86
EBIT 75 112 160 231 316
EBITDA 119 163 212 355 445
Net Profit 71 99 131 158 185
Net Profit Adjusted 71 98 133 - -
Pre-Tax Profit 73 111 158 233 309
Pre-Tax Profit Reported 76 106 127 - -
EPS (Non-GAAP) ex. SOE 1.76 2.34 3.08 3.88 -
EPS (GAAP) 1.82 2.49 3.00 3.67 4.26
Gross Income 353 436 518 650 730
Cash Flow from Investing -26 -27 -29 - -
Cash Flow from Operations 113 139 173 - -
Cash Flow from Financing - - 0 - -
Cash Flow per Share 2.83 3.48 4.23 - -
Free Cash Flow 42 69 145 - -
Free Cash Flow per Share -0.17 0.60 - - -
Book Value per Share 8.92 12.37 16.39 - -
Net Debt 163 86 -82 - -
Research & Development Exp. 77 92 102 119 101
Capital Expenditure 26 27 29 - -
Selling, General & Admin. Exp. 202 234 259 300 314
Shareholder’s Equity 359 498 677 - -
Total Assets 950 1,092 1,255 - -
  Previous Quarter
ending 03/31/25 		Current Quarter
ending 06/30/25 		Next Quarter
ending 09/30/25 		Current Year
ending 12/31/25 		Next Year
ending 12/31/26
Earnings Estimates
No. of Analysts - 10 10 10 10
Average Estimate - 0.445 USD 0.311 USD 1.838 USD 2.537 USD
Year Ago - 0.368 USD 0.126 USD 1.067 USD -
Publish Date - 7/31/2025 11/11/2025 - -
Revenue Estimates
No. of Analysts - 9 9 10 10
Average Estimate - 147 USD 141 USD 580 USD 701 USD
Year Ago - 114 USD 109 USD 442 USD -
Publish Date - 7/31/2025 11/11/2025 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

2024 2023 2022 2021 2020 2019 2018
Sales 441.54 241.62 93.46 30.26 25.64 23.60 13.02
Change of sales in % 82.74 158.53 208.83 18.03 8.62 81.33 69.38
Gross profit on sales 261.88 153.99 65.27 21.16 16.36 13.64 5.57
Gross profit on sales change in % 70.06 135.93 208.48 29.35 19.92 145.12 191.82
Operating income 37.50 0.49 -31.44 -39.43 -26.38 -29.60 -20.24
Operating income change in % 7,631.13 - 20.27 -49.44 10.87 -46.28 0.93
Income before tax 35.78 -26.67 -36.17 -44.18 -28.72 -33.51 -23.72
Income before tax change in % - 26.25 18.14 -53.85 14.30 -41.29 -14.06
Income after tax 35.46 -25.03 -36.23 -44.22 -28.75 -33.55 -23.76
Income after tax change in % - 30.92 18.06 -53.80 14.31 -41.21 -14.09

Balance Sheet in Mio. USD

2024 2023 2022 2021 2020 2019 2018
Total liabilities 599.83 568.85 89.77 67.04 48.14 50.65 47.88
Long-term liabilities per share 16.06 15.73 2.06 1.58 1.33 1.63 1.77
Equity 228.60 137.20 187.38 67.85 103.89 54.65 -5.72
Equity change in % 66.62 -26.78 176.14 -34.69 90.11 - -13.94
Balance sheet total 828.43 706.05 277.15 134.89 152.03 105.30 42.16
Balance sheet total change in % 17.33 154.76 105.46 -11.27 44.38 149.78 13.93

Key Data in USD

2024 2023 2022 2021 2020 2019 2018
Sales per share 12.54 7.43 3.16 1.10 1.04 1.66 0.65
P/E ratio (year end quote, basic EPS) 61.92 - - - - - -
P/E ratio (year end quote, diluted EPS) 61.92 - - - - - -
Dividend yield in % 0.00 0.00 0.00 0.00 0.00 0.00 -
Equity ratio in % 27.59 19.43 67.61 50.30 68.34 51.90 -13.58
Debt ratio in % 72.41 80.57 32.39 49.70 31.66 48.10 113.58

TransMedics Group Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
Ranganath Anil P. 06/08/2025 686.00 13,955.00 139.80 Sell No
Basile Edward M 05/26/2025 5,000.00 2,866.00 126.45 Sell No
Basile Edward M 05/26/2025 5,000.00 7,866.00 0.70 Buy No
Weill David 05/22/2025 732.00 12,134.00 123.88 Sell No
RAINES MERILEE 05/21/2025 2,134.00 4,059.00 n/a Buy No
TOBIN JAMES R 05/21/2025 2,134.00 4,059.00 n/a Buy No
Gunderson Thomas James 05/21/2025 2,134.00 4,059.00 n/a Buy No
Basile Edward M 05/21/2025 2,134.00 2,866.00 n/a Buy No
Lovell Stephanie 05/21/2025 2,134.00 4,059.00 n/a Buy No
KANIA EDWIN M JR 05/21/2025 2,134.00 260,810.00 n/a Buy No
Weill David 05/21/2025 2,134.00 12,866.00 n/a Buy No
Basile Edward M 05/08/2025 6,000.00 732.00 115.63 Sell No
Basile Edward M 05/08/2025 6,000.00 6,732.00 0.70 Buy No
Corcoran Nicholas 02/23/2025 12,676.00 33,781.00 n/a Buy No
Hernandez Gerardo 02/23/2025 3,521.00 15,984.00 n/a Buy No
Khayal Tamer I 02/23/2025 17,606.00 38,449.00 n/a Buy No
Khayal Tamer I 01/06/2025 1,083.00 20,843.00 80.05 Sell No
Khayal Tamer I 01/06/2025 1,083.00 21,926.00 13.28 Buy No
Hernandez Gerardo 12/08/2024 12,463.00 12,463.00 n/a Buy No
Khayal Tamer I 12/01/2024 1,084.00 20,843.00 86.40 Sell No
Khayal Tamer I 12/01/2024 1,084.00 21,927.00 13.28 Buy No
Khayal Tamer I 11/10/2024 1,458.00 20,843.00 90.04 Sell No
Khayal Tamer I 11/10/2024 1,458.00 22,301.00 38.46 Buy No
Basile Edward M 11/04/2024 1,454.00 732.00 84.30 Sell No
Basile Edward M 11/04/2024 5,296.00 2,186.00 83.35 Sell No

TransMedics Group Dividend Calendar

Date Name Dividend *yield Currency
2024 TransMedics Group Inc Registered Shs 0.00 0.00 USD
2023 TransMedics Group Inc Registered Shs 0.00 0.00 USD
2022 TransMedics Group Inc Registered Shs 0.00 0.00 USD
2021 TransMedics Group Inc Registered Shs 0.00 0.00 USD
2020 TransMedics Group Inc Registered Shs 0.00 0.00 USD
2019 TransMedics Group Inc Registered Shs 0.00 0.00 USD
2018 TransMedics Group Inc Registered Shs - - USD
2017 TransMedics Group Inc Registered Shs - - USD
2016 TransMedics Group Inc Registered Shs - - USD
*Yield of the Respective Date

TransMedics Group Calendar

Event Estimate Info Date
Earnings Report 0.445 USD Q2 2025 Earnings Release 07/31/2025
Earnings Report 0.311 USD Q3 2025 Earnings Release 11/11/2025
Earnings Report 0.395 USD Q4 2025 Earnings Release 03/04/2026
Earnings Report 0.713 USD Q1 2026 Earnings Release 05/05/2026

TransMedics Group Past Events

Event Actual EPS Info Date
Annual General Meeting 1.010 USD Annual General Meeting 05/22/2025
Earnings Report 0.700 USD Q1 2025 Earnings Release 05/08/2025
Earnings Report 0.190 USD Q4 2024 Earnings Release 02/27/2025
Earnings Report 0.120 USD Q3 2024 Earnings Release 10/28/2024
Earnings Report 0.350 USD Q2 2024 Earnings Release 07/31/2024
Annual General Meeting -0.770 USD Annual General Meeting 05/23/2024
Earnings Report 0.350 USD Q1 2024 Earnings Release 04/30/2024
Earnings Report 0.120 USD Q4 2023 Earnings Release 02/26/2024
Earnings Report -0.780 USD Q3 2023 Earnings Release 11/06/2023
Earnings Report -0.030 USD Q2 2023 Earnings Release 08/03/2023
Annual General Meeting -1.230 USD Annual General Meeting 05/25/2023
Earnings Report -0.080 USD Q1 2023 Earnings Release 05/01/2023
Earnings Report -0.210 USD Q4 2022 Earnings Release 02/22/2023
Earnings Report -0.250 USD Q3 2022 Earnings Release 11/03/2022
Earnings Report -0.410 USD Q2 2022 Earnings Release 08/01/2022
Annual General Meeting -1.600 USD Annual General Meeting 06/01/2022
Earnings Report -0.380 USD Q1 2022 Earnings Release 05/03/2022
Earnings Report -0.460 USD Q4 2021 Earnings Release 02/23/2022

TransMedics Group Profile

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
OSZAR »